Clinical Efficacy and Long-term Outcomes of ALLOgraft Versus Stented Biological Prosthesis for Primary TRIcuspid Valve Disease (ALLOTRI)

计划入组 56 人 · 首次发布于 2024 年 9 月 11 日

Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery

计划入组 30 人 · 首次发布于 2024 年 1 月 9 日

A Study to Identify Differences in Gene Expression in Patients With Bicuspid and Tricuspid Valve Disease

计划入组 91 人 · 首次发布于 2010 年 9 月 3 日

liver disease program

siRNA therapeutics for ocular disease/dermatological disease (Phio Pharmaceuticals)

undisclosed drug (fibrotic liver disease/NASH), Engitix/Takeda

THUBRIKAR AORTIC VALVE INC

United States

HERSHEY VALVE CO., LTD.

Taiwan

Rare Disease Research, LLC

FDA Approves Pivotal Trial for Novel Tricuspid Valve Repair Device MIA-T

First Patient in Hampton Roads Receives TricValve Implant in FDA Breakthrough Device Trial for Severe Tricuspid Regurgitation

New Transcatheter Tricuspid Valve Treatments Offer Hope for High-Risk Cardiac Patients